Published in Biol Psychiatry on January 25, 2006
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (2006) 5.89
Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci (2010) 3.95
Stress- and allostasis-induced brain plasticity. Annu Rev Med (2011) 3.06
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44
Integrity of white matter in the corpus callosum correlates with bimanual co-ordination skills. Neuroimage (2007) 1.92
Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci (2010) 1.90
Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology (2011) 1.85
REDD1 is essential for stress-induced synaptic loss and depressive behavior. Nat Med (2014) 1.77
Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease. Neuroimage (2007) 1.68
Acquiring "the Knowledge" of London's layout drives structural brain changes. Curr Biol (2011) 1.60
Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience (2009) 1.49
Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat (2009) 1.48
BDNF val66met polymorphism influences motor system function in the human brain. Cereb Cortex (2009) 1.46
Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci (2009) 1.46
The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist (2011) 1.43
Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults. PLoS One (2015) 1.42
Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One (2010) 1.36
The impact of poverty on the development of brain networks. Front Hum Neurosci (2012) 1.34
Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors. Cereb Cortex (2007) 1.33
Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience (2009) 1.33
Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One (2009) 1.32
Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav (2012) 1.31
Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology (2011) 1.25
Disruption of orbitofrontal cortex laterality in offspring from multiplex alcohol dependence families. Biol Psychiatry (2008) 1.21
A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology (2010) 1.21
Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex (2013) 1.20
Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor. Phys Ther (2013) 1.17
Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res (2009) 1.16
Neurogenesis and schizophrenia: dividing neurons in a divided mind? Eur Arch Psychiatry Clin Neurosci (2007) 1.12
BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism. Neuropsychopharmacology (2009) 1.11
Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J Clin Psychiatry (2011) 1.11
Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J Neural Transm (Vienna) (2010) 1.09
Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol Dis (2012) 1.07
Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci (2006) 1.06
Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther (2008) 1.06
Imaging genetics of mood disorders. Neuroimage (2010) 1.06
Impact of genetic variant BDNF (Val66Met) on brain structure and function. Novartis Found Symp (2008) 1.06
Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology (2008) 1.05
The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology (Berl) (2010) 1.04
Cognitive enhancers for anxiety disorders. Pharmacol Biochem Behav (2010) 1.04
Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. Eur Arch Psychiatry Clin Neurosci (2011) 1.04
Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet (2007) 1.03
The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep (2012) 1.02
Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophr Res (2010) 1.02
The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. Mol Psychiatry (2015) 1.02
Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biol Mood Anxiety Disord (2013) 1.01
Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults. PLoS One (2012) 0.99
Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm (Vienna) (2007) 0.99
The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. Am J Geriatr Psychiatry (2010) 0.98
Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci (2010) 0.98
BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activity. Transl Psychiatry (2012) 0.98
Effects and mechanisms of working memory training: a review. Psychol Res (2013) 0.98
Cerebellum volume in high-risk offspring from multiplex alcohol dependence families: association with allelic variation in GABRA2 and BDNF. Psychiatry Res (2011) 0.97
Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am J Geriatr Psychiatry (2011) 0.97
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol (2011) 0.96
Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants. Croat Med J (2009) 0.96
The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci (2009) 0.95
From the neurobiology of extinction to improved clinical treatments. Depress Anxiety (2013) 0.94
Molecular actions and clinical pharmacogenetics of lithium therapy. Pharmacol Biochem Behav (2014) 0.94
Genetic patterns of correlation among subcortical volumes in humans: results from a magnetic resonance imaging twin study. Hum Brain Mapp (2011) 0.94
No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain Behav (2011) 0.94
Neural plasticity, human genetics, and risk for alcohol dependence. Int Rev Neurobiol (2010) 0.94
Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.93
Imaging genetics and development: challenges and promises. Hum Brain Mapp (2010) 0.92
Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals. Genes Brain Behav (2012) 0.92
BDNF genotype modulates resting functional connectivity in children. Front Hum Neurosci (2009) 0.91
Gray matter volume in adolescent anxiety: an impact of the brain-derived neurotrophic factor Val(66)Met polymorphism? J Am Acad Child Adolesc Psychiatry (2013) 0.91
BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Res (2010) 0.91
Neurotrophic gene polymorphisms and response to psychological therapy. Transl Psychiatry (2012) 0.90
Brain-derived neurotrophic factor val66met polymorphism and hippocampal activation during episodic encoding and retrieval tasks. Hippocampus (2010) 0.90
Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol Psychiatry (2008) 0.90
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity. Drug Discov Today (2016) 0.90
Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet (2012) 0.89
BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict Biol (2012) 0.89
BDNF polymorphism predicts general intelligence after penetrating traumatic brain injury. PLoS One (2011) 0.88
Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration. PLoS One (2013) 0.88
The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2012) 0.87
Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One (2012) 0.87
Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J Neural Transm (Vienna) (2011) 0.86
Genome-wide interaction analysis reveals replicated epistatic effects on brain structure. Neurobiol Aging (2014) 0.84
The role of brain-derived neurotrophic factor genotype, parental depression, and relationship discord in predicting early-emerging negative emotionality. Psychol Sci (2010) 0.84
BDNF val66met polymorphism affects aging of multiple types of memory. Brain Res (2014) 0.83
Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. PLoS One (2014) 0.83
Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment. Psychiatr Clin North Am (2013) 0.83
BDNF Val66Met polymorphism influences age differences in microstructure of the Corpus Callosum. Front Hum Neurosci (2009) 0.83
Pathogenesis of depression: Insights from human and rodent studies. Neuroscience (2015) 0.82
Neurobiology of memory and anxiety: from genes to behavior. Neural Plast (2007) 0.82
Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease. Neuroreport (2010) 0.82
Interaction between CRHR1 and BDNF genes increases the risk of recurrent major depressive disorder in Chinese population. PLoS One (2011) 0.81
BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Transl Psychiatry (2011) 0.81
Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. J Psychiatr Res (2012) 0.81
Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers. Neuroimage Clin (2013) 0.81
Age-Related Olfactory Decline is Associated with the BDNF Val66met Polymorphism: Evidence from a Population-Based Study. Front Aging Neurosci (2010) 0.81
Is it all in the family? The effects of early social structure on neural-behavioral systems of prairie voles (Microtus ochrogaster). Neuroscience (2012) 0.81
Genetic Modulation of Training and Transfer in Older Adults: BDNF ValMet Polymorphism is Associated with Wider Useful Field of View. Front Psychol (2011) 0.80
The serotonin transporter linked polymorphic region and brain-derived neurotrophic factor valine to methionine at position 66 polymorphisms and maternal history of depression: associations with cognitive vulnerability to depression in childhood. Dev Psychopathol (2013) 0.80
Caudate nucleus-dependent navigational strategies are associated with increased use of addictive drugs. Hippocampus (2013) 0.80
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cogn Affect Behav Neurosci (2015) 0.80
Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. Alcohol (2014) 0.80
The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37
Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain (2005) 7.80
The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry (2011) 6.66
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A (2009) 3.49
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry (2008) 3.47
Neurobiological mechanisms of the placebo effect. J Neurosci (2005) 3.41
Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A (2007) 3.33
Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet (2004) 3.11
Individual differences in reward responding explain placebo-induced expectations and effects. Neuron (2007) 2.96
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci (2007) 2.19
A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology (2002) 2.07
Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci (2006) 1.79
Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol (2012) 1.76
To knockout in 129 or in C57BL/6: that is the question. Trends Genet (2004) 1.76
New insights into the genetics of addiction. Nat Rev Genet (2009) 1.70
Early menopausal hormone use influences brain regions used for visual working memory. Menopause (2010) 1.67
Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner. Biol Psychiatry (2012) 1.61
Dysregulation of regional endogenous opioid function in borderline personality disorder. Am J Psychiatry (2010) 1.57
Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci (2006) 1.54
Tissue-specific functional networks for prioritizing phenotype and disease genes. PLoS Comput Biol (2012) 1.54
Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry (2006) 1.52
Neuronal and non-neuronal functions of the AP-3 sorting machinery. J Cell Sci (2007) 1.52
Genetical genomics: combining genetics with gene expression analysis. Hum Mol Genet (2005) 1.49
Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Neuroimage (2009) 1.49
Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biol Psychiatry (2007) 1.48
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
SNPs on chips: the hidden genetic code in expression arrays. Biol Psychiatry (2006) 1.36
Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Neuropsychopharmacology (2006) 1.35
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A (2011) 1.29
Mutation of a novel gene results in abnormal development of spermatid flagella, loss of intermale aggression and reduced body fat in mice. Genetics (2002) 1.29
Affective circuitry and risk for alcoholism in late adolescence: differences in frontostriatal responses between vulnerable and resilient children of alcoholic parents. Alcohol Clin Exp Res (2008) 1.22
Striatal dysfunction marks preexisting risk and medial prefrontal dysfunction is related to problem drinking in children of alcoholics. Biol Psychiatry (2010) 1.19
Face emotion perception and executive functioning deficits in depression. J Clin Exp Neuropsychol (2005) 1.19
Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology (2003) 1.18
Nucleus accumbens response to incentive stimuli anticipation in children of alcoholics: relationships with precursive behavioral risk and lifetime alcohol use. J Neurosci (2012) 1.17
Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res (2009) 1.16
Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.16
A task to manipulate attentional load, set-shifting, and inhibitory control: convergent validity and test-retest reliability of the Parametric Go/No-Go Test. J Clin Exp Neuropsychol (2006) 1.15
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008) 1.14
Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat Genet (2003) 1.12
Future of genetics of mood disorders research. Biol Psychiatry (2002) 1.11
Practical aspects of in vivo detection of neuropeptides by microdialysis coupled off-line to capillary LC with multistage MS. Anal Chem (2009) 1.11
Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J Clin Endocrinol Metab (2006) 1.10
Utilization and barriers to mental health services among depressed medical interns: a prospective multisite study. J Grad Med Educ (2010) 1.10
Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology (2012) 1.09
Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.08
Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol Psychiatry (2010) 1.07
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain (2013) 1.06
Serotonin transporter and GABAA alpha 6 receptor variants are associated with neuroticism. Biol Psychiatry (2004) 1.06
Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.05
Accumbens functional connectivity during reward mediates sensation-seeking and alcohol use in high-risk youth. Drug Alcohol Depend (2012) 1.05
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res (2011) 1.05
The missing p in psychiatric training: why it is important to teach pain to psychiatrists. Arch Gen Psychiatry (2011) 1.04
Mouse models for psychiatric disorders. Trends Genet (2002) 1.04
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. Am J Hum Genet (2012) 1.04
Immediate effects of tDCS on the μ-opioid system of a chronic pain patient. Front Psychiatry (2012) 1.04
Real-time sharing and expression of migraine headache suffering on Twitter: a cross-sectional infodemiology study. J Med Internet Res (2014) 1.03
Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. Am J Med Genet B Neuropsychiatr Genet (2008) 1.02
Pathogenesis of clinical signs in recessive ataxia with saccadic intrusions. Ann Neurol (2003) 1.02
Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry (2011) 1.01
Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry (2009) 1.00
The sensitivity and psychometric properties of a brief computer-based cognitive screening battery in a depression clinic. Psychiatry Res (2007) 1.00
Increased activity of Diaphanous homolog 3 (DIAPH3)/diaphanous causes hearing defects in humans with auditory neuropathy and in Drosophila. Proc Natl Acad Sci U S A (2010) 0.99
MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int J Neuropsychopharmacol (2009) 0.99
The Effect of Question Framing and Response Options on the Relationship between Racial Attitudes and Beliefs about Genes as Causes of Behavior. Public Opin Q (2010) 0.98
Gender-specific disruptions in emotion processing in younger adults with depression. Depress Anxiety (2009) 0.97
Altered central micro-opioid receptor binding after psychological trauma. Biol Psychiatry (2006) 0.96
SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. Psychiatr Genet (2009) 0.95
Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys (2005) 0.95
Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause (2008) 0.95
Well-being and the risk of depression under stress. PLoS One (2013) 0.94
fMRI BOLD responses to negative stimuli in the prefrontal cortex are dependent on levels of recent negative life stress in major depressive disorder. Psychiatry Res (2010) 0.94
Serotonin transporter gene, stress and raphe-raphe interactions: a molecular mechanism of depression. Trends Neurosci (2012) 0.94
Alterations in endogenous opioid functional measures in chronic back pain. J Neurosci (2013) 0.94
Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene. Psychiatr Genet (2006) 0.93
Protocol for a collaborative meta-analysis of 5-HTTLPR, stress, and depression. BMC Psychiatry (2013) 0.93
Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy. Fertil Steril (2008) 0.92
Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. J Neurosci (2008) 0.92
Resiliency in adolescents at high risk for substance abuse: flexible adaptation via subthalamic nucleus and linkage to drinking and drug use in early adulthood. Alcohol Clin Exp Res (2012) 0.92
DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. Cortex (2012) 0.92
Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans. J Neurosci (2012) 0.92
Hormonal environment affects cognition independent of age during the menopause transition. J Clin Endocrinol Metab (2012) 0.92
Sex differences in anterior cingulate cortex activation during impulse inhibition and behavioral correlates. Psychiatry Res (2012) 0.92
Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health bipolar sample. Am J Med Genet B Neuropsychiatr Genet (2008) 0.92
Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biol Psychiatry (2006) 0.91
Family-based association analysis to finemap bipolar linkage peak on chromosome 8q24 using 2,500 genotyped SNPs and 15,000 imputed SNPs. Bipolar Disord (2010) 0.91
The CC genotype in HTR2A T102C polymorphism is associated with behavioral impulsivity in alcohol-dependent patients. J Psychiatr Res (2011) 0.89
BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict Biol (2012) 0.89
Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89
Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia. Arthritis Rheumatol (2015) 0.89
Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans. J Neurosci (2014) 0.89
The role of the endogenous opioid system in polycystic ovary syndrome. Fertil Steril (2009) 0.88
Family-based SNP association study on 8q24 in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.88
The XVth World Congress of Psychiatric Genetics, October 7-11, 2007: Rapporteur summaries of oral presentations. Am J Med Genet B Neuropsychiatr Genet (2008) 0.88
HPA axis activation in major depression and response to fluoxetine: a pilot study. Psychoneuroendocrinology (2004) 0.88
Reduced emotion processing efficiency in healthy males relative to females. Soc Cogn Affect Neurosci (2012) 0.87
Short-term hormone treatment modulates emotion response circuitry in postmenopausal women. Fertil Steril (2009) 0.87
Impact of chronic hypercortisolemia on affective processing. Neuropharmacology (2011) 0.87